University of Bath
Bath, United Kingdom
NCT Number: NCT03232034
Gut hormones have therapeutic potential in the prevention and treatment obesity and type 2 diabetes (T2D). Milk protein and calcium can each potentiate gut hormones following meal ingestion in humans. However, these nutrients may interact synergistically (and with other minerals in milk) such that specific co-ingestion of these nutrients is required to obtain the full therapeutic potential for metabolism and energy balance. This proposal is to perform a pilot study on the effect of co-ingesting Capolac® plus protein on circulating gut hormone responses.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Bath, United Kingdom
Participants will be asked to arrive to the laboratory between 08:00 and 10:00 am after not eating for between 8-14 hours i.e. in a fasted state (water intake is permitted and encouraged). Participants will then be given one of three test drinks: 1) calcium citrate (1000 mg); 2) milk mineral supplement (equating to 1000 mg calcium); or 3) milk mineral supplement (equating to 1000 mg calcium) plus whey protein hydrolysate (50 g). Each of these drinks will also contain 500 mL of water and artificial sweetener (80 mg sucralose).
Blood samples will be taken before, and at 15, 30, 45, 60, 90 and 120 minutes after ingestion of the test drink to determine the concentrations of gut hormones (GIP, GLP-1 and PYY) circulating in the bloodstream. We will also ask participants to complete an appetite questionnaire at baseline and every 30 minutes after ingestion of the test drink to assess their appetite sensations. After the 120-minute time point, we will remove the cannula and the trial day will be complete.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
1000 mg calcium as calcium citrate
Milk Minerals containing 1000 mg calcium
50 g whey protein hydrolysate
Time frame: 120 min
Plasma glucagon-like peptide-1 (GLP-1) concentrations
Time frame: 120 min
Plasma glucose-dependent insulinotropic peptide (GIP) concentrations
Time frame: 120 min
Plasma peptide tyrosine tyrosine (PYY) concentrations.
Time frame: 120 min
Visual analogue scales of appetite ratings
Time frame: 120 min
Carbohydrate and fat oxidation (g/h) measured via indirect calorimetry
Time frame: 120 min
Plasma glucose concentrations (mmol/L).
Time frame: 120 min
Systolic and diastolic blood pressure
University of Bath
Other
The Role of Dietary Milk Minerals and Protein in Gut Hormone Secretion
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00065676
Body Weight, Diabetes
Bethesda, Maryland, United States
View Trial DetailsNCT00862433
Body Weight, Diabetes
Bethesda, Maryland, United States
View Trial DetailsNCT01809288
Behavior, Body Weight
Bethesda, Maryland, United States
View Trial DetailsNCT01501201
Body Weight, Diabetes
Lille, Nord, France
View Trial Details